arrow
J

Jeffrey R. Willis

genentech, inc.
H指数:22
被引数:2,146

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase I Study of the Anti-interleukin 33 Fragment Antigen-Binding Region RO7303359 in Geographic Atrophy Secondary to Age-Related Macular Degeneration

I期研究:抗白介素33片段抗原结合区RO7303359在年龄相关性黄斑变性继发性地理萎缩中的应用

2025-04-200
OAAI
Two-Year Results from the Phase 3 Neovascular Age- Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2

Faricimab治疗和延长给药2年的3期新生血管性年龄相关性黄斑变性试验的两年结果

2024-08-0124
OA
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
LANCET
IF88.5
2022-02-01213
OAAI